Lily Lam is listed as a director on 1 SEC Form D filing by 1 issuer in Mar 2012: Azelon Pharmaceuticals, Inc. (West Conshohocken, PA — pharmaceuticals — 2012; $9.13M reported sold to 16 investors).
What this means One deal on file with the SEC, filed Mar 2012. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Donald Hayden (1 shared filing), Joan Lau (1 shared filing) and Joseph Zakrzewski (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Lily. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name, 1 bankruptcy case matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.